Abbott Laboratories to launch new drug at Arab Health Exhibition
The Chicago-based Abbott Laboratories, plans to launch its erectile dysfunction drug in the Middle East at this year’s Arab Health exhibition, to be held January 26-29 at the Dubai World Trade Center, according to a company press release. The company will also be showcasing Reductil, a new weight management drug recently launched in the region.
Abbott Laboratories is an international health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, nutritional, and medical products, including devices and diagnostics. The company employs approximately 70,000 people and markets its products in more than 130 countries. — (menareport.com)
© 2002 Mena Report (www.menareport.com)
- Abbott Laboratories introduces acute decompensated heart failure treatment in the UAE
- Abbott Laboratories launches ProSure in the UAE
- TECHNIDATA signs new partnership with BADER SULTAN & BROS in Kuwait and will exhibit at Arab Health 2009 to develop its presence in the Middle East.
- 3M health organises scientific educational sessions during arab health exhibition and congress 2012